Roche Pharmaceuticals – Business Overview

scientist at a lab

Roche Pharma at a glance:

  • Focused on translating excellence in science into break-through medicines for patients
  • One of the leading developers of targeted treatments combined with corresponding diagnostics
  • The world’s largest biotech company
  • The world’s leading provider of cancer treatments

Roche Pharmaceuticals – Business overview

Roche Pharmaceuticals is focused on translating excellence in science into effective medicines for patients. It combines cutting-edge research at Roche, Genentech in the US, Chugai in Japan and over 150 partners worldwide with global scale and reach in clinical development, manufacturing and commercial operations. Thanks to the Pharmaceuticals Division’s broad-based portfolio, Roche is one of the world’s leading providers of clinically differentiated medicines.

Focus on innovation

Roche Pharmaceuticals is living proof that scientific invention leads to products that truly save and improve patients’ lives. Roche’s inspiring tradition of excellence in science dates back more than a century. Today, as then, our strategy is rooted in fostering excellence in science and empowering scientists to create breakthroughs in life science that will make a difference tomorrow.

Focusing on oncology, immunology, ophthalmology, infectious diseases and neuroscience, we firmly believe in the tremendous potential to translate science into therapies which reduce human suffering and help people live longer and healthier lives.

The world’s number 1 in biotech

Roche is the world’s largest biotech company. Biotechnology plays a crucial role both in the elucidation of the molecular causes of disease and in the development of new diagnostic methods and better targeted drugs. Over half of the compounds in our product pipeline are biopharmaceuticals, enabling us to deliver better-targeted therapies.

The world’s leading provider of cancer treatments

Cancer remains the second leading cause of death in the industrialized world and its incidence is growing. But if detected early enough, many forms of the disease can be effectively treated. We have been at the forefront of cancer research and treatment for over 50 years. Our medicines treat breast, skin, colon, ovarian, lung and numerous other cancers. Roche currently has a number of innovative cancer drugs on the market. They give patients the most important thing in life: time to live.

Contribution to sustainable healthcare

Twenty-nine medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and chemotherapy.